CJC-1295 Ipamorelin Blend
CJC-1295 Ipamorelin Blend
CJC-1295 Ipamorelin Blend | High-Purity Research Compound
✔ Purity: ≥99%
✔ Form: Lyophilised powder
✔ Storage (unreconstituted): Store at -20°C, away from light and moisture
✔ Storage (reconstituted): Store at 2–8°C, use within 30–45 days. Do not freeze.
✔ Composition: CJC-1295 (No DAC) + Ipamorelin
For Research Use Only. Not intended for human or veterinary use.
The CJC-1295 Ipamorelin Blend combines two well-characterised growth hormone secretagogues into a single research compound. SHPeptide supplies this blend at high purity for use in controlled laboratory and research settings only.
About CJC-1295 Ipamorelin Blend
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) that has been modified with a Drug Affinity Complex (DAC) to extend its half-life through albumin binding. Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist, notable for its high GH-release specificity with minimal effect on other pituitary hormones. Together, these two peptides act on complementary receptor pathways — GHRH receptors and ghrelin/GHS receptors — making this blend a valuable tool for researchers investigating synergistic growth hormone secretion mechanisms and the GH/IGF-1 axis.
Research Applications
- Synergistic GHRH and ghrelin receptor pathway studies
- Growth hormone pulsatility and secretion kinetics research
- GH/IGF-1 axis regulation and downstream anabolic signalling studies
- Comparative secretagogue pharmacology and receptor selectivity research
- Hypothalamic-pituitary axis function in in vitro and ex vivo models
Product Information
Stability: Stable for 24 months when stored correctly
Solubility: Soluble in water and aqueous buffers
Quality Assurance
All SHPeptide compounds are manufactured under strict quality control conditions. Each batch is independently tested for identity, purity, and potency. Certificates of Analysis (CoA) are available upon request.
This product is intended solely for laboratory research purposes. It is not approved for human or animal administration, and must be handled by qualified professionals in an appropriate research environment. SHPeptide accepts no liability for misuse of this compound.